Furthermore, IL-4 has been shown to maintain survival of CML cells on TKI inhibition [49] and is known to antagonize MHC-II and CIITA expression [50, 51], which promotes immune evasion [52]. The gene discussed is IL4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.